A new survey from Nielsen is hoping to shed light on the world's socially conscious consumers, who are those that are willing to pay extra for products and services from companies that implement programs designed to give back to society.
Retailers that use tablets and other mobile devices in place of cash registers are perceived as being more innovative by mobile shoppers than those that do not, according to the latest AisleBuyer survey.
When it comes to healthy habits, dietary supplement users appear to make healthier lifestyle choices overall than nonusers, according to a recent study by the Council for Responsible Nutrition released Thursday.
More than 5.1 million seniors and people with disabilities on Medicare saved billions on prescription drugs, thanks to the Patient Protection and Affordable Care Act, according to Department of Health and Human Services secretary Kathleen Sebelius.
During the 2011 holiday season, the top retail applications and websites combined — including Amazon, Best Buy, eBay, Target and Walmart — reached nearly 60% of smartphone owners, according to Nielsen.
Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.
Many Walgreens customers are "flocking" to independent pharmacies amid the dispute between the retail pharmacy chain and pharmacy benefit manager Express Scripts, a trade group representing the PBM industry said.
While consumers will continue to define value based on price, other key trends — including new product development, technology, store layouts and shopping patterns — will drive the market in 2012, according to SymphonyIRI research.
Abbott is set to enroll patients into two late-stage clinical trials designed to evaluate the safety and efficacy of one of its drugs as a treatment for a difficult-to-treat chronic inflammatory skin disease.
A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.